Literature DB >> 10491018

Morphological-histochemical study of intestinal carcinoids and K-ras mutation analysis in appendiceal carcinoids.

H Paraskevakou1, A Saetta, K Skandalis, S Tseleni, A Athanassiadis, P S Davaris.   

Abstract

Intestinal carcinoids are potentially malignant neoplasms. Their histogenesis and pathogenesis are currently uncertain. The morphological and histochemical characteristics of twenty intestinal carcinoids are studied. The primary sites of three mucin-producing tumors were examined by electron microscope. Furthermore 11 appendiceal carcinoids were analysed by the polymerase chain reaction (PCR) for the detection of ras and p53 point mutations. Microscopically all carcinoids were of mixed type. Focal mucin production was evident in three carcinoids that metastasised to regional lymph nodes. HID-Alcian blue staining proved that mucin in both primary and secondary foci did not belong to the sulphated group. The secretory granules and mucin droplets found in a single neoplastic cell suggest that carcinoids of the small intestine and some of the appendix arise from the endoderm. Neither ras nor p53 mutations were detected. It seems that ras oncogenes are probably not involved in the pathogenesis of appendiceal carcinoids.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491018     DOI: 10.1053/paor.1999.0193

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  33 in total

1.  DIAMINE METHODS FOR DIFFERENTIALING MUCOSUBSTANCES HISTOCHEMICALLY.

Authors:  S S SPICER
Journal:  J Histochem Cytochem       Date:  1965-03       Impact factor: 2.479

2.  Carcinoid tumours of the appendix are different.

Authors:  P A Shaw
Journal:  J Pathol       Date:  1990-11       Impact factor: 7.996

3.  Gastrointestinal carcinoid tumours: histological, histochemical and immunohistochemical study.

Authors:  G C Raju; Y S Lee
Journal:  Ann Acad Med Singapore       Date:  1988-01       Impact factor: 2.473

4.  Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases.

Authors:  J Soga; K Tazawa
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

5.  Goblet cell carcinoid of the appendix.

Authors:  F H Rodriguez; D P Sarma; J H Lunseth
Journal:  Hum Pathol       Date:  1982-03       Impact factor: 3.466

6.  The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors.

Authors:  N Younes; N Fulton; R Tanaka; J Wayne; F H Straus; E L Kaplan
Journal:  Cancer       Date:  1997-05-01       Impact factor: 6.860

7.  A comparative immunohistochemical study of jejunoileal and appendiceal carcinoids. Implications for histogenesis and pathogenesis.

Authors:  T N Moyana; N Satkunam
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860

8.  Subepithelial neuroendocrine cells and carcinoid tumours of the human small intestine and appendix. A comparative immunohistochemical study with regard to serotonin, neuron-specific enolase and S-100 protein reactivity.

Authors:  M Lundqvist; E Wilander
Journal:  J Pathol       Date:  1986-02       Impact factor: 7.996

9.  Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons.

Authors:  S Alpert; D Hanahan; G Teitelman
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

10.  Endocrine cell hyperplasia and appendiceal carcinoids.

Authors:  S S Cross; A D Hughes; G T Williams; E D Williams
Journal:  J Pathol       Date:  1988-12       Impact factor: 7.996

View more
  5 in total

Review 1.  Historical, current and future perspectives on gastrointestinal and pancreatic endocrine tumors.

Authors:  Susanne van Eeden; G Johan A Offerhaus
Journal:  Virchows Arch       Date:  2005-10-12       Impact factor: 4.064

2.  ZM336372, a Raf-1 activator, causes suppression of proliferation in a human hepatocellular carcinoma cell line.

Authors:  Dustin Deming; Peter Geiger; Herbert Chen; Abram Vaccaro; Muthusamy Kunnimalaiyaan; Kyle Holen
Journal:  J Gastrointest Surg       Date:  2008-05       Impact factor: 3.452

Review 3.  Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors.

Authors:  Scott N Pinchot; Susan C Pitt; Rebecca S Sippel; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Curr Opin Investig Drugs       Date:  2008-06

4.  Tautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathway.

Authors:  Scott N Pinchot; Joel T Adler; Yinggang Luo; Jianhua Ju; Wenli Li; Ben Shen; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  Am J Surg       Date:  2009-03       Impact factor: 2.565

Review 5.  PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms.

Authors:  Franziska Briest; Patricia Grabowski
Journal:  Theranostics       Date:  2014-01-29       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.